Home > Cashflow Statement > INDO US BIOTECH

INDO US BIOTECH
Cashflow Statement

COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Cashflow Statement History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹8.80 Cr₹7.39 Cr₹5.49 Cr₹4.13 Cr₹2.86 Cr
Adjustment ₹2.25 Cr₹2.02 Cr₹1.62 Cr₹1.42 Cr₹1.10 Cr
Changes In working Capital ₹-15 Cr₹-8.56 Cr₹-3.81 Cr₹-5.19 Cr₹-4.77 Cr
Cash Flow after changes in Working Capital ₹-4.27 Cr₹0.84 Cr₹3.30 Cr₹0.36 Cr₹-0.81 Cr
Cash Flow from Operating Activities ₹-4.58 Cr₹0.53 Cr₹2.91 Cr₹0.22 Cr₹-0.84 Cr
Cash Flow from Investing Activities ₹4.28 Cr₹-6.67 Cr₹-5.40 Cr₹-1.75 Cr₹-0.57 Cr
Cash Flow from Financing Activities ₹1.22 Cr₹6.29 Cr₹2.41 Cr₹1.46 Cr₹1.53 Cr
Net Cash Inflow / Outflow ₹0.91 Cr₹0.14 Cr₹-0.08 Cr₹-0.07 Cr₹0.12 Cr
Opening Cash & Cash Equivalents ₹0.19 Cr₹0.05 Cr₹0.13 Cr₹0.20 Cr₹0.08 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹1.10 Cr₹0.19 Cr₹0.05 Cr₹0.13 Cr₹0.20 Cr

Compare Cashflow Statement of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹334.4 Cr -15.4% 8.7% -19.1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,614.2 Cr -0.2% 1% -10.7% Stock Analytics
KAVERI SEED COMPANY ₹5,775.8 Cr -0.1% -4% 5.4% Stock Analytics
VENKYS (INDIA) ₹2,174.9 Cr -1.1% -4% -19.4% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,426.4 Cr -1.8% -3.1% -29.6% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹559.3 Cr -0.4% 13.6% NA Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-15.4%

8.7%

-19.1%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses